Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A

Pawel Mroz, Fatma Vatansever, Angelika Muchowicz, Michael R. Hamblin

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Photodynamic therapy (PDT) involves the intravenous administration of photosensitizers followed by illumination of the tumor with visible light, leading to local production of reactive oxygen species that cause vascular shutdown and tumor cell death. Antitumor immunity is stimulated after PDT because of the acute inflammatory response that involves activation of the innate immune system, leading to stimulation of adaptive immunity. We carried out PDT using benzoporphyrin derivative and 690-nm light after 15 minutes, in DBA/2 mice bearing either the mastocytoma, P815, which expresses the naturally occurring cancer/testis antigen P1A, or the corresponding tumor P1.204 that lacks P1A expression. Tumor cures, significantly higher survival, and rejection of tumor rechallenge were obtained with P815, which were not seen with P1.204 or seen with P815 growing in nude mice. Both CD4 and CD8 T cells had higher levels of intracellular cytokines when isolated from mice receiving PDT of P815 tumors than P1.204 tumors and CD8 T cells from P815-cured mice recognized the peptide epitope of the P1A antigen (LPYLGWLVF) using pentamer staining. Taken together, these findings show thatPDTcan induce a potent antigen- and epitope-specific immune response against a naturally occurring mouse tumor antigen.

Original languageEnglish (US)
Pages (from-to)6462-6470
Number of pages9
JournalCancer Research
Volume73
Issue number21
DOIs
StatePublished - Nov 1 2013

Fingerprint

Dive into the research topics of 'Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A'. Together they form a unique fingerprint.

Cite this